Teleflex Establishes New Multi-Bank Credit Agreement Facility
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Teleflex ( (TFX) ) has shared an update.
On May 26, 2026, Teleflex entered into a new multi-bank credit agreement that refinances its November 2022 facility and establishes a capital structure anchored by a $1.0 billion five-year revolving credit line, a $500 million term A-1 loan and a $700 million term A-2 loan. The borrowings are guaranteed by substantially all material domestic subsidiaries and secured by liens on most company and guarantor assets, including equity in key domestic and certain foreign units.
The new revolving and term A-1 facilities mature on May 26, 2031, while the term A-2 facility matures on May 26, 2028, with interest tied to Term SOFR or an alternate base rate, subject to pricing based on Teleflex’s leverage or corporate family rating. The agreement imposes customary covenants, including caps on additional debt and liens, use-of-proceeds restrictions, information and compliance obligations, and maintenance of a maximum total net leverage ratio of 4.50x and minimum interest coverage of 3.00x, with potential acceleration and foreclosure remedies if events of default occur.
The most recent analyst rating on (TFX) stock is a Hold with a $143.00 price target. To see the full list of analyst forecasts on Teleflex stock, see the TFX Stock Forecast page.
Spark’s Take on TFX Stock
According to Spark, TipRanks’ AI Analyst, TFX is a Neutral.
The score is held back primarily by weak financial performance (large recent losses and revenue contraction) and poor valuation optics (negative P/E). These are partially offset by solid cash flow/leverage improvement, constructive technical momentum, and reaffirmed guidance alongside a post-separation margin recovery plan—though near-term margin, remediation, and execution/timing risks remain notable.
To see Spark’s full report on TFX stock, click here.
More about Teleflex
Teleflex Incorporated is a medical technology company that designs, develops and supplies specialty medical devices used in critical care and surgical applications. The company focuses on providing disposable products and vascular, anesthesia, cardiac care and surgical instruments to hospitals and healthcare providers worldwide, supporting patient care and procedural efficiency.
Average Trading Volume: 850,076
Technical Sentiment Signal: Sell
Current Market Cap: $5.88B
For an in-depth examination of TFX stock, go to TipRanks’ Overview page.
